Sanmina Corp. Hits Day Low at $251.66 Amid Price Pressure

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 10.01% to touch an intraday low of USD 251.66. This performance stands in contrast to the S&P 500, which fell by 2.64% on the same day. Despite today's downturn, Sanmina Corp. has shown strong performance metrics over the past year, boasting a remarkable 193.01% increase compared to the S&P 500's 24.32%. The company's year-to-date performance is also noteworthy, with a gain of 67.97%. Over the last five years, Sanmina has achieved an impressive 492.99% increase, reflecting its robust growth trajectory. Financially, Sanmina Corp. is net-debt free and has demonstrated high management efficiency, evidenced by a return on equity (ROE) of 12.64%. The company reported a substantial net profit growth of 90.01% in its latest results, alongside record operating cash flow of USD 977.35 million and net sales of USD 4,013.27 million. Promoter confidence is also on the rise, with a recent increase in their stake by 2.11%.